Michael Deininger

I am a physician-scientist focused on myeloid malignancies. My lab studies leukemogenesis to discover new therapy targets to improve patient outcomes.

[Versiti Blood Research Institute @VersitiResearch]

Check out publication with VBRI Senior Research Scientist Nataly Cruz-Rodriquez who is in Dr. Deininger's Lab @MWDeininger and collaborators MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL https://t.co/gGaAqmVrGc

[Michael Deininger @MWDeininger]

Our review on inflammation and dormancy in myeloid malignancies just came out in Blood. Hope you’ll find it useful.

#alwaysstressed

https://t.co/Uq1N0iAMgC

[Michael Deininger @MWDeininger]

#NewProfilePic